Indoline compounds for inhibiting KIF18A
US12084420B2 · kind B2 · utility
0Cited by
5References
35Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 25, 2022 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | Aug 25, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/5728
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to inhibitors of KIF18A, compositions thereof, and methods of using the compounds and compositions thereof. More specifically, the present disclosure relates to indoline inhibitors of KIF18A and methods of their use for treating disease mediated by KIF18A, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.